Horizon Therapeutics
HZNP
$116.30
Share price
0.00%
Change (1 day)
5.68%
Change (1 year)
Categories
Operating Margin for Horizon Therapeutics (HZNP)
Operating Margin as of April 2024 (TTM): 14.06%
According to Horizon Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 14.06%. At the end of 2022 the company had an Operating Margin of 14.52%.
Operating Margin history for Horizon Therapeutics from 2011 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 14.52% | 1.22% |
| 2021 | 14.34% | -21.41% |
| 2020 | 18.25% | -1273.33% |
| 2019 | -1.56% | -84.23% |
| 2018 | -9.87% | -79.7% |
| 2017 | -48.59% | 109.03% |
| 2016 | -23.25% | 32.61% |
| 2015 | -17.53% | -80.7% |
| 2014 | -90.82% | -55.22% |
| 2013 | -202.83% | -57.17% |
| 2012 | -473.54% | -74.36% |
| 2011 | -1,847.09% | 58.29% |
| 2010 | -1,166.88% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | 146.16% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 146.02% | 🇺🇸 USA |
 Merck MRK | 27.73% | 97.23% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -59.96% | 🇬🇧 UK |
 Dr. Reddy's RDY | 24.69% | 75.60% | 🇮🇳 India |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.